← Back to Screener
Stryker Corporation (SYK)
Price$305.66
Value ScoreC
Growth ScoreC
Momentum ScoreC
Favorite Metrics
Price vs S&P 500 (26W)-25.58%
Price vs S&P 500 (4W)7.08%
VGM Score47.51
Market Capitalization$117.18B
P/E Ratio (Annual)36.10x
Indicated Dividend Yield (Annual)1.17%
All Metrics
P/CF (Annual)23.23x
Book Value / Share (Quarterly)$59.93
P/TBV (Annual)8.03x
Indicated Dividend (Annual)$3.52
Revenue Growth (3Y)10.83%
Cash Flow / Share (Quarterly)$11.92
Payout Ratio (TTM)38.99%
Price vs S&P 500 (YTD)-21.19%
Gross Margin (TTM)64.24%
Net Profit Margin (TTM)13.21%
EPS (TTM)$8.63
10-Day Avg Trading Volume2.96M
EPS Excl Extra (TTM)$8.63
Revenue Growth (5Y)11.84%
EPS (Annual)$8.40
Dividend / Share (Annual)$3.36
ROI (Annual)8.48%
Gross Margin (Annual)64.57%
Net Profit Margin (5Y Avg)13.21%
Cash / Share (Quarterly)$7.73
P/E Basic Excl Extra (TTM)35.11x
Revenue Growth QoQ (YoY)2.63%
EPS Growth (5Y)14.84%
P/E Normalized (Annual)36.10x
ROA (Last FY)6.78%
Revenue Growth TTM (YoY)8.84%
EBITD / Share (TTM)$14.78
ROE (5Y Avg)14.72%
Operating Margin (TTM)19.66%
Cash Flow / Share (Annual)$11.20
P/B Ratio5.10x
P/B Ratio (Quarterly)5.48x
Net Income / Employee (Annual)$58,000
EV / Revenue (TTM)5.11x
Net Interest Coverage (TTM)10.29x
ROA (TTM)7.12%
EPS Growth QoQ (YoY)13.89%
EV / EBITDA (TTM)22.58x
EPS Incl Extra (Annual)$8.40
Current Ratio (Annual)1.89x
Quick Ratio (Quarterly)1.03x
3-Month Avg Trading Volume2.39M
52-Week Price Return-20.21%
EV / Free Cash Flow (Annual)30.12x
P/E Incl Extra (TTM)35.11x
Revenue / Employee (TTM)$451,200
Tangible BV / Share (Quarterly)$45.55
P/S Ratio (Annual)4.67x
Asset Turnover (Annual)0.53x
52-Week High$404.87
Operating Margin (5Y Avg)17.04%
EPS Excl Extra (Annual)$8.40
CapEx CAGR (5Y)9.34%
Tangible BV CAGR (5Y)17.32%
26-Week Price Return-17.65%
Quick Ratio (Annual)1.04x
13-Week Price Return-17.50%
Total Debt / Equity (Annual)0.71x
Current Ratio (Quarterly)2.11x
Enterprise Value$129.02B
Revenue / Share Growth (5Y)11.48%
Asset Turnover (TTM)0.54x
Book Value / Share Growth (5Y)11.00%
Revenue / Employee (Annual)$448,500
Inventory Turnover (Annual)1.76x
Pretax Margin (Annual)17.97%
Cash / Share (Annual)$10.72
3-Month Return Std Dev29.11%
Gross Margin (5Y Avg)64.02%
Net Income / Employee (TTM)$59,600
EBITDA CAGR (5Y)15.73%
EBITDA Interim CAGR (5Y)11.16%
ROE (Last FY)14.48%
Net Interest Coverage (Annual)4.70x
EPS Basic Excl Extra (Annual)$8.40
P/FCF (TTM)25.64x
Receivables Turnover (TTM)6.71x
EV / Free Cash Flow (TTM)28.23x
Total Debt / Equity (Quarterly)0.64x
EPS Incl Extra (TTM)$8.63
Receivables Turnover (Annual)6.26x
ROI (TTM)8.88%
Dividend Growth Rate (5Y)7.89%
P/S Ratio (TTM)4.64x
Pretax Margin (5Y Avg)15.84%
Revenue / Share (Annual)$64.98
Tangible BV / Share (Annual)$43.76
Forward P/E19.44x
Free OCF CAGR (5Y)8.95%
Price vs S&P 500 (52W)-44.58%
P/E Ratio (TTM)35.11x
EPS Growth TTM (YoY)16.51%
Year-to-Date Return-13.03%
5-Day Price Return2.07%
EPS Normalized (Annual)$8.40
ROA (5Y Avg)6.77%
Net Profit Margin (Annual)12.92%
Month-to-Date Return0.19%
Cash Flow / Share (TTM)$9.43
EBITD / Share (Annual)$14.47
EPS Growth (3Y)10.83%
Operating Margin (Annual)19.36%
LT Debt / Equity (Annual)0.66x
P/CF (TTM)21.80x
ROI (5Y Avg)8.50%
P/E Excl Extra (TTM)35.11x
LT Debt / Equity (Quarterly)0.62x
EPS Basic Excl Extra (TTM)$8.63
P/TBV (Quarterly)7.21x
Payout Ratio (Annual)39.56%
P/B Ratio (Annual)6.00x
Dividend / Share (TTM)$3.40
Inventory Turnover (TTM)1.72x
Pretax Margin (TTM)18.20%
Book Value / Share (Annual)$58.61
Price vs S&P 500 (13W)-25.76%
Net Margin Growth (5Y)3.01%
Dividend Yield (TTM)1.11%
Beta0.78x
P/FCF (Annual)27.36x
Revenue / Share (TTM)$65.38
ROE (TTM)15.10%
52-Week Low$281.00
vGradeC
gGradeC
mGradeC
vgmGradeC
Show chart for
Earnings Surprise History
Q1 262.60est. 3.01
Analyst Recommendations
Feb 2026
Mar 2026
Apr 2026
May 2026
4.06
4.08
4.08
4.11
Industry Peers — Surgical & Medical Instruments(138)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
SYKStryker Corporation | C | C | C | $305.66 |
| MMM3M Company | C | F | C | $153.76 |
| BSXBoston Scientific Corp. | C | B | D | $48.55 |
| MDLNMedline Inc. Class A common stock | C | D | D | $33.61 |
| BDXBecton, Dickinson and Co. | B | C | C | $151.16 |
| RMDResMed Inc. | C | B | C | $196.04 |
| DXCMDexCom, Inc. | C | B | C | $72.86 |
| WSTWest Pharmaceutical Services, Inc. | D | C | B | $314.50 |
| SOLVSolventum Corporation | C | D | B | $81.01 |
| PENPenumbra, Inc. | F | C | B | $320.53 |
| GMEDGLOBUS MEDICAL INC | B | A | C | $80.00 |
About
Stryker manufactures and markets orthopedic implants, medical devices, and hospital equipment serving surgical and patient care settings. The company holds leading market positions in reconstructive orthopedics and operating room equipment, with products including joint replacements, endoscopy systems, robotics, and hospital beds. As one of the top three reconstructive orthopedic competitors, Stryker generates approximately one-quarter of revenues internationally.